Professional Documents
Culture Documents
To Interpret
interpret explain the meaning of (information, words, or actions)
To Interpret
analyse susceptibility results based: organism identification all antibiotic results (pattern) interpret susceptibility based on above
Courvalin P. Interpretive reading of in vitro antibiotic susceptibility tests (the antibiogramme). Clinical Microbiology and Infection. 1996;2:S26S34.
Why interpret?
To detect unusual results that need further testing or confirmation To report appropriate antibiotic results for the organism-infection combination To detect emerging resistance
Expert rule
Description of action to be taken, based on current evidence, in response to specific antimicrobial susceptibility test results
E X P E R T R U L E
If you obey all of the rules, you miss all of the fun. - Katharine Hepburn
Actions
Recommendations on reporting
E X P E R T R U L E
Suppression of results Addition of comments Advice on further tests Advice on referral of isolates
Brown, D. Concepts and needs for expert rules and intrepretive reading of the antibiogram. The EUCAST perspective
Requirements
Identification of the organism (fully)
E X P E R T R U L E
May need to test an extended range of appropriate antibiotics Access to a set of expert rules
Part One
INTRINSIC RESISTANCE
I N T R I N S I C R E S I S T A N C E
Examples
I N T R I N S I C R E S I S T A N C E
Organism Enterobacteriaceae Gram-positive organism Klebsiella species Proteus mirabilis Serratia marcescens
I N T R I N S I C R E S I S T A N C E
Livermore DM, et al. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother. 2001 Jul 1;48(suppl 1):87102
I N T R I N S I C R E S I S T A N C E
http://www.eucast.org/expert_rules/
Part Two
ANTIBIOGRAM READING
A N T I B I O G R A M R E A D I N G
Test susceptibility Infer resistance mechanism Interpret clinical susceptibility on the basis of the resistance mechanism
Canton, R. Expert Rules In Susceptibility Testing Rationale, Advantage And Disadvantages. ECCMID 31 March-3 April, 2012
Species identification
Antibiotic susceptibility
E X P E R T R U L E
REPORT
E X P E R T R U L E
additional tests deduce biochemical resistance 1. re-define susceptibility (categorical) 2. deduce susceptibility to non-tested antibiotics 3. clinical comments 4. clinical advice
REPORT
Simple..
A N T I B I O G R A M R E A D I N G
More complicated..
A N T I B I O G R A M R E A D I N G
Enterobacteriaceae Result:
tobramycin non-susceptible amikacin & gentamicin susceptible
Infer: Interpret:
Escherichia coli
A N T I B I O G R A M R E A D I N G
Antibiotic Ampicillin Amoxicillin-clavulanate Piperacillin-tazobactam Cephalothin Ceftriaxone Ceftazidime Cefepime Cefoxitin Ertapenem Gentamicin Amikacin Ciprofloxacin Trimethoprim-sulfamethoxazole
Category R S S R R S R S S S S S S
Interpret: Consider reporting ceftazidime as resistant OR Reporting presence of ESBL with comment
Klebsiella pneumoniae
A N T I B I O G R A M R E A D I N G
Antibiotic Ampicillin Amoxicillin-clavulanate Piperacillin-tazobactam Cephalothin Ceftriaxone Ceftazidime Cefepime Cefoxitin Ertapenem Gentamicin Amikacin Ciprofloxacin Trimethoprim-sulfamethoxazole
Category R R S R I R S R S S S S S
Limitations
High complexity of resistance mechanisms Limited information about some mechanisms of resistance Multifactorial multiresistance Oversimplification of interpretative reading Mistakes when deducing mechanisms of resistance
Part Three
EXCEPTIONAL PHENOTYPE
E X C E P T I O N A L P H E N O T Y P E
E X C E P T I O N A L P H E N O T Y P E
Examples
E X C E P T I O N A L P H E N O T Y P E
Streptococcus pyogenes resistant to penicillin Staphylococcus aureus resistant to vancomycin Haemophilus inuenzae resistant to any thirdgeneration cephalosporin, carbapenems, and uoroquinolones
Examples
E X C E P T I O N A L P H E N O T Y P E
Anaerobes resistant to metronidazole Neisseria gonorrhoeae resistant to third-generation cephalosporin Enterobacteriaceae resistant to carbapenems
HOW TO BE AN EXPERT
Antibiotic Amoxicillin-clavulanate Piperacillin-tazobactam Ceftriaxone Ceftazidime Cefepime Imipenem Ertapenem Meropenem Amikacin Gentamicin Ciprofloxacin Trimethoprimsulfamethoxazole
Zone (mm) 6 6 6 26 18 6 6 6 6 6 30 35
Result R R R
ICU patient 28 days in hospital oxidase negative non-fermentative Gramnegative bacillus What is the likely organism?
R R R R R
Enterobacter cloacae
Antibiotic Amoxicillinclavulanate Cefoxitin Ceftriaxone Ceftazidime Cefepime Imipenem Ertapenem Meropenem Ciprofloxacin Trimethoprimsulfamethoxazole Zone (mm) 6 6 27 26 24 24 23 24 25 20 Result R R S S S S S S S S
Enterobacter cloacae
Antibiotic Amoxicillinclavulanate Cefoxitin Ceftriaxone Ceftazidime Cefepime Imipenem Ertapenem Meropenem Ciprofloxacin Trimethoprimsulfamethoxazole Zone (mm) 6 6 27 26 24 24 23 24 25 20 Result R R S S S S S S S S
ARTIFICIAL INTELLIGENCE
Vitek AES
Summary
Systems vary in accuracy design update frequency See Winstanley T, Courvalin P. Expert Systems in Clinical Microbiology. Clin Microbiol Rev. 2011; 24(3):51556.
Conclusions
Some resistant organisms may need supplemental methods to detect Susceptibility testing can be complicated Resistance mechanism or tested MIC? Not yet quite sure.